The 2-oxindole chemotype and patent activity inspired by the SU5416 franchise

By Connell Richard D  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 737-749

Informa Healthcare

Access to resources Recommend Favorite

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

By Fury Matthew   Zahalsky Andrew   Wong Richard   Venkatraman Ennapadam   Lis Eric   Hann Lucy   Aliff Timothy   Gerald William   Fleisher Martin   Pfister David  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

A phase I Study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance

By Salzberg Marc   Pless Miklos   Rochlitz Christoph   Ambrus Klara   Scigalla Paul   Herrmann Richard  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 299-304

Springer Publishing Company

Access to resources Recommend Favorite

Translational Science in Medicine: Implications for the Pharmaceutical Industry

By Wehling Martin  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 5, 2006-01 ,pp. : 303-310

Adis International

Access to resources Recommend Favorite

Cross-Border Trade Policy Implications for the Pharmaceutical Industry

By Freeman Robert A.  

Journal of Pharmaceutical Marketing & Management, Vol. 16, Iss. 3, 2005-07 ,pp. : 71-78

Haworth Press

Access to resources Recommend Favorite